Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study

被引:75
作者
Andersen, Vibeke [1 ]
Ostergaard, Mette [1 ,2 ]
Christensen, Jane [3 ]
Overvad, Kim [4 ]
Tjonneland, Anne [3 ]
Vogel, Ulla [5 ,6 ]
机构
[1] Viborg Reg Hosp, Dept Med, DK-8800 Viborg, Denmark
[2] Viborg Reg Hosp, Dept Clin Biochem, DK-8800 Viborg, Denmark
[3] Danish Canc Soc, Inst Canc Epidemiol, DK-2100 Copenhagen, Denmark
[4] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-9100 Aalborg, Denmark
[5] Natl Res Ctr Working Environm, DK-2100 Copenhagen, Denmark
[6] Tech Univ Denmark, Natl Food Inst, DK-2860 Soborg, Denmark
关键词
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; P-GLYCOPROTEIN EXPRESSION; GENETIC POLYMORPHISMS; COLON-CANCER; FUNCTIONAL POLYMORPHISMS; CIGARETTE-SMOKING; PROTEIN GENE; CYCLOOXYGENASE-2; SUSCEPTIBILITY; COX-2;
D O I
10.1186/1471-2407-9-407
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The xenobiotic transporters, Multidrug Resistance 1 (MDR1/ABCB1) and Breast Cancer Resistance Protein (BCRP/ABCG2) may restrict intestinal absorption of various carcinogens, including heterocyclic amines (HCA) and polycyclic aromatic hydrocarbons (PAH). Cyclooxygenase-2 (COX-2) derived prostaglandins promote gastrointestinal carcinogenesis, affecting angiogenesis, apoptosis, and invasiveness. The aim of this study was to investigate if polymorphisms in these genes were associated with risk of colorectal cancer (CRC), and to investigate possible interactions with lifestyle factors such as smoking, meat consumption, and NSAID use. Methods: The following polymorphisms were analyzed; a synonymous MDR1 C3435T (rs1045642) in exon26, G-rs3789243-A in intron3, the functional BCRP C421A (rs2231142), the two COX-2 A-1195G (rs689466) and G-765C (rs20417) in the promoter region, and the COX-2 T8473C (rs5275) polymorphisms in the 3'-untranslated region. The polymorphisms were assessed together with lifestyle factors in a nested case-cohort study of 359 cases and a random cohort sample of 765 participants from the Danish prospective Diet, Cancer and Health study. Results: Carriers of the variant allele of MDR1 intron 3 polymorphism were at 1.52-fold higher risk of CRC than homozygous wild type allele carriers (Incidence rate ratio (IRR) = 1.52, 95% Confidence Interval (CI): 1.12-2.06). Carriers of the variant allele of MDR1 C3435T exon 26 had a lower risk of CRC than homozygous C-allele carriers (IRR = 0.71 (CI: 0.50-1.00)). There was interaction between these MDR1 polymorphisms and intake of red and processed meat in relation to CRC risk. Homozygous MDR1 C3435T C-allele carriers were at 8% increased risk pr 25 gram meat per day (CI: 1.00-1.16) whereas variant allele carriers were not at increased risk (p for interaction = 0.02). COX-2 and BCRP polymorphisms were not associated with CRC risk. There was interaction between NSAID use and MDR1 C3435T and COX-2 T8473C (p-values for interaction 0.001 and 0.04, respectively). Conclusion: Two polymorphisms in MDR1 were associated with CRC risk and there was interaction between these polymorphisms and meat intake in relation to CRC risk. Our results suggest that MDR1 polymorphisms affect the relationship between meat and CRC risk.
引用
收藏
页数:11
相关论文
共 71 条
[1]   Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver [J].
Albermann, N ;
Schmitz-Winnenthal, FH ;
Z'graggen, K ;
Volk, C ;
Hoffmann, MM ;
Haefeli, WE ;
Weiss, J .
BIOCHEMICAL PHARMACOLOGY, 2005, 70 (06) :949-958
[2]   Biochemical, cellular, and pharmacological aspects of the multidrug transporter [J].
Ambudkar, SV ;
Dey, S ;
Hrycyna, CA ;
Ramachandra, M ;
Pastan, I ;
Gottesman, MM .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 :361-398
[3]   The multidrug resistance 1 (MDR1) gene polymorphism G-rs3789243-A is not associated with disease susceptibility in Norwegian patients with colorectal adenoma and colorectal cancer; a case control study [J].
Andersen, Vibeke ;
Agerstjerne, Lene ;
Jensen, Dorte ;
Ostergaard, Mette ;
Saebo, Mona ;
Hamfjord, Julian ;
Kure, Elin ;
Vogel, Ulla .
BMC MEDICAL GENETICS, 2009, 10
[4]   Influence of cigarette smoking on prostaglandin synthesis and cyclooxygenase-2 gene expression in human urinary bladder cancer [J].
Badawi, AF ;
Habib, SL ;
Mohammed, MA ;
Abadi, AA ;
Michael, MS .
CANCER INVESTIGATION, 2002, 20 (5-6) :651-656
[5]   Effects of genetic polymorphisms of MDR1, FMO3 and CYP1A2 on susceptibility to colorectal cancer in Koreans [J].
Bae, Sun-Young ;
Choi, Sun-Keun ;
Kim, Kyung-Rae ;
Park, Chang-Shin ;
Lee, Sung-Keun ;
Roh, Hyung-Keun ;
Shin, Dong-Woon ;
Pie, Jae-Eun ;
Woo, Ze-Hong ;
Kang, Ju-Hee .
CANCER SCIENCE, 2006, 97 (08) :774-779
[6]   ROBUST VARIANCE-ESTIMATION FOR THE CASE-COHORT DESIGN [J].
BARLOW, WE .
BIOMETRICS, 1994, 50 (04) :1064-1072
[7]   Analysis of case-cohort designs [J].
Barlow, WE ;
Ichikawa, L ;
Rosner, D ;
Izumi, S .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1999, 52 (12) :1165-1172
[8]  
BARRY EL, 2009, CANC EPIDEMIOL BIOMA
[9]  
BUQARE AW, 2003, J TOXICOL ENV HEAL B, V6, P279
[10]   A gene-wide investigation on polymorphisms in the ABCG2/BRCP transporter and susceptibility to colorectal cancer [J].
Campa, Daniele ;
Pardini, Barbara ;
Naccarati, Alessio ;
Vodickova, Ludmila ;
Novotny, Jan ;
Forsti, Asta ;
Hemminki, Kari ;
Barale, Roberto ;
Vodicka, Pavel ;
Canzian, Federico .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2008, 645 (1-2) :56-60